Riehl melanosis
https://en.wikipedia.org/wiki/Riehl_melanosis
☆ Natiijooyinka Stiftung Warentest ee 2022 ee ka yimid Jarmalka, ku qanacsanaanta macaamilka ee ModelDerm ayaa waxyar uun ka hooseysay la-talinta telemedicine-ka ee lacagta lagu bixiyo. relevance score : -100.0%
References
Riehl Melanosis 32491369 NIH
Riehl melanosis inta badan waxaa loo yaqaannaa maqaarka maqaarka midabka leh. Waa nooc ka mid ah xaaladaha maqaarka ee ay keento xasaasiyadda, badanaa waxaa kicisa udgoonka iyo walxaha kale ee laga helo alaabta qurxinta. Inkasta oo lagu sifeeyay nooc ka mid ah dermatitis, Riehl melanosis waxay muujinaysaa isbeddellada midabka maqaarka, oo leh calaamado yaryar oo xanaaq ah. Waxay aad ugu badan tahay dadka midabada maqaarka madow leh. Cilmi-baaristii ugu dambeysay waxay sahamisay waxtarka mid-fluence QSNY 1064-nm daaweynta laysarka si wax looga qabto midabaynta qoto dheer ee la xiriirta Riehl melanosis. Daraasad kale ayaa isku daray daweyno kala duwan, oo ay ku jiraan low-fluence 1064-nm Q-switched Nd: YAG laser, kareem hydroquinone, iyo tranexamic acid afka, taasoo keentay horumar la taaban karo oo bukaanada intooda badan.
Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.
Research Advances in the Treatment of Riehl’s Melanosis 37168093 NIH
Riehl's melanosis waa nooc ka mid ah xaaladaha maqaarka ee ka yimaada taabashada xasaasiyadaha qaarkood iyo soo-gaadhista iftiinka qorraxda. Waxay u horseedaa si dhakhso ah, midab-cawlan-brown ah oo maqaarka ah, kaas oo si weyn u saameyn kara bukaanka maskax ahaan iyo jir ahaanba. Iyadoo sababta saxda ah ee Riehl's melanosis aan wali la garanayn, cilmi-baadhisyada hadda jirta waxay muujinaysaa xidhiidh xooggan oo la leh soo-gaadhista xasaasiyadda. Daawaynta, daawaynta dhaqameed iyo daawaynta laysarka labadaba waa la isku dayay, inta badan waxa barbar socda isticmaalka walxaha bleaching ee maqaarka lagu mariyo. Daaweynta laser-ka, gaar ahaan iyadoo la adeegsanayo Q-switched Nd:YAG laser, waxay muujisay natiijooyin rajo leh oo lagu daaweynayo Riehl's melanosis. Isku darka habab daaweyn oo kala duwan ayaa keenay natiijooyin wanaagsan.
Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.